In Vitro Chemoresistance and Chemosensitivity Assays
This reimbursement policy governs whether Blue Cross Blue Shield of New Mexico will reimburse in vitro chemosensitivity and chemoresistance assays for covered members and provides coding guidance for claims submission.
Added new CPT code 0525U effective 01/01/2025.
Document updated with literature review; added code 0453U previously.
Coverage Criteria
Non-reimbursable services
Reimbursement Information
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.